Relay Therapeutics, Inc. (RLAY)
Company Info
| ISIN | US75943R1023 |
|---|---|
| CUSIP | 75943R102 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $1.23B |
|---|---|
| EPS (TTM) | -$2.52 |
| Total Revenue (TTM) | $35.21M |
| Gross Profit (TTM) | $29.71M |
| EBITDA (TTM) | -$370.10M |
| Year Range | $5.70 - $12.14 |
| Target Price | $22.30 |
| Short % | 8.67% |
| Short Ratio | 10.69 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: RLAY vs. NRBO, RLAY vs. RXRX
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Relay Therapeutics, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Relay Therapeutics, Inc. had a return of -31.15% year-to-date (YTD) and -17.52% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -31.15% | 17.79% |
| 1 month | 4.84% | 0.18% |
| 6 months | -5.13% | 7.53% |
| 1 year | -17.52% | 26.42% |
| 5 years (annualized) | N/A | 13.48% |
| 10 years (annualized) | N/A | 10.85% |
Monthly Returns
The table below presents the monthly returns of RLAY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -15.99% | 8.32% | -17.17% | -21.45% | -1.69% | 1.72% | 26.07% | -17.40% | -31.15% | ||||
| 2023 | 43.64% | -24.74% | 1.98% | -30.97% | -2.02% | 12.75% | 0.32% | -18.89% | -17.71% | -21.52% | 19.85% | 39.19% | -26.31% |
| 2022 | -27.94% | 8.95% | 24.14% | -20.38% | -31.68% | 2.89% | 13.55% | 20.77% | -2.61% | -0.67% | -16.38% | -19.59% | -51.35% |
| 2021 | 19.30% | -16.76% | -16.23% | -8.27% | 1.29% | 13.92% | -11.34% | -1.26% | -1.56% | 5.46% | -11.52% | 4.38% | -26.11% |
| 2020 | 1.17% | 13.34% | 5.97% | -13.27% | 44.32% | -22.04% | 18.57% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of RLAY is 38, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Relay Therapeutics, Inc. (RLAY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Relay Therapeutics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Relay Therapeutics, Inc. was 90.41%, occurring on Apr 23, 2024. The portfolio has not yet recovered.
The current Relay Therapeutics, Inc. drawdown is 87.68%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -90.41% | Jan 25, 2021 | 817 | Apr 23, 2024 | — | — | — |
| -30.98% | Nov 27, 2020 | 30 | Jan 11, 2021 | 6 | Jan 20, 2021 | 36 |
| -25.4% | Jul 20, 2020 | 20 | Aug 14, 2020 | 24 | Sep 18, 2020 | 44 |
| -21.35% | Oct 6, 2020 | 21 | Nov 3, 2020 | 6 | Nov 11, 2020 | 27 |
| -15.72% | Sep 22, 2020 | 5 | Sep 28, 2020 | 5 | Oct 5, 2020 | 10 |
Volatility
Volatility Chart
The current Relay Therapeutics, Inc. volatility is 48.60%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Relay Therapeutics, Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
| Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
| Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |